Hemosiderosis

Common Name(s)

Hemosiderosis

Hemosiderosis is a rare condition where there is too much iron in the body and the blood. This condition can result in long-lasting damage to organs. The liver, lungs and kidneys are usually the most affected organs. Symptoms vary according to the organs affected. Hemosiderosis can be diagnosed with a variety of tests including blood tests, imaging tests, and potentialy biopsies of affected organs, which is where a small needle is used to take a piece of the organ to look at under a microscope. Treatment focuses on removing iron from the body. This may be done with different medications and sometime phlebotomy, or purposefully bleeding.

Source: Advocacy organizations associated with the condition.

 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Hemosiderosis" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Hemosiderosis" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Hemosiderosis" returned 58 free, full-text research articles on human participants. First 3 results:

Welder's pulmonary hemosiderosis associated with systemic iron overload following exacerbation of acute adult T-cell leukemia/lymphoma.
 

Author(s): Naoto Imoto, Akira Shiraki, Katsuya Furukawa, Naoyuki Tange, Atsushi Murase, Masaya Hayakawa, Yosuke Iwata, Hiroshi Kosugi

Journal: J Clin Exp Hematop. 2017 Oct;57(2):74-78.

 

Herein, we describe a 61-year-old man diagnosed with pulmonary hemosiderosis following chemotherapy for acute adult T-cell leukemia/lymphoma (ATLL). Liver and heart biopsy confirmed hemosiderosis. ATLL progressed, and the patient died from multiorgan damage. Welder's lung may have ...

Last Updated: 31 Dec 1969

Go To URL
Residual erythropoiesis protects against myocardial hemosiderosis in transfusion-dependent thalassemia by lowering labile plasma iron via transient generation of apotransferrin.
 

Author(s): Maciej W Garbowski, Patricia Evans, Evangelia Vlachodimitropoulou, Robert Hider, John B Porter

Journal: Haematologica. 2017 10;102(10):1640-1649.

 

Cardiosiderosis is a leading cause of mortality in transfusion-dependent thalassemias. Plasma non-transferrin-bound iron and its redox-active component, labile plasma iron, are key sources of iron loading in cardiosiderosis. Risk factors were identified in 73 patients with or without ...

Last Updated: 31 Dec 1969

Go To URL
Correlation between Heart, Liver and Pancreas Hemosiderosis Measured by MRI T2* among Thalassemia Major Patients from Iran.
 

Author(s): Azita Azarkeivan, Mozhgan Hashemieh, Afshan Shirkavand, Kourosh Sheibani

Journal: Arch Iran Med. 2016 Feb;19(2):96-100.

 

Major thalassemia patients need lifelong transfusions. The consequence of these repeated transfusions is iron accumulation in different organs. The main aim of the present study was to investigate the correlation between heart, liver and pancreas hemosiderosis in thalassemic patients from Iran.

Last Updated: 31 Dec 1969

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Hemosiderosis" returned 4 free, full-text review articles on human participants. First 3 results:

[Idiopathic pulmonary hemosiderosis with dendriform pulmonary ossification].
 

Author(s): Ana Madeleine Barrera, Leslie Vargas

Journal:

 

Pulmonary ossification is a rare and usually asymptomatic finding reported as incidental in lung biopsies. Similarly, idiopathic pulmonary hemosiderosis is a rare cause of pulmonary infiltrates. We report the case of a 64-year old man with chronic respiratory symptoms in whom these ...

Last Updated: 31 Dec 1969

Go To URL
Unexplained childhood anaemia: idiopathic pulmonary hemosiderosis.
 

Author(s): K K Siu, Rever Li, S Y Lam

Journal: Hong Kong Med J. 2015 Apr;21(2):172-4.

 

This report demonstrates pulmonary haemorrhage as a differential cause of anaemia. Idiopathic pulmonary hemosiderosis is a rare disease in children; it is classically described as a triad of haemoptysis, pulmonary infiltrates on chest radiograph, and iron-deficiency anaemia. However, ...

Last Updated: 31 Dec 1969

Go To URL
[Porphyria cutanea tarda, hemosiderosis and hepatocellular carcinoma: report of one case].
 

Author(s): Carolina Whittle, Juan Hepp, Rodolfo Armas, Marcela Schultz

Journal: Rev Med Chil. 2010 May;138(5):581-5.

 

Porphyria cutanea tarda (PCT) is a hereditary or acquired disease. It can be unleashed by iron overload, alcohol, estrogens and other conditions. In these patients, hepatic involvement can be associated to cirrhosis, iron overload or C and B viral infections, that are predisposing ...

Last Updated: 31 Dec 1969

Go To URL
 
 
Top

Symptoms, Diagnosis, and Treatment

There are currently no related results available in GeneReviews.

There are currently no related results available in Genetic Testing Registry.

 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

Efficacy of Bone Marrow Mesenchymal Stem Cell in Pulmonary Hemosiderosis
 

Status: Not yet recruiting

Condition Summary: Idiopathic Pulmonary Hemosiderosis

 

Last Updated: 6 Dec 2016

Go to URL

Last Updated: 10 Oct 2018

Go to URL
Florbetaben as an Amyloid Plaque Marker in Elderly Patients With Focal or Disseminated Superficial Hemosiderosis
 

Status: Not yet recruiting

Condition Summary: Amyloid Cerebral Angiopathy; Alzheimer Disease

 

Last Updated: 8 Mar 2018

Go to URL